NCT00987844View on ClinicalTrials.gov

Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

1,775

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

November 30, 2000

Conditions
Chronic Constipation
Interventions
DRUG

Prucalopride

1 mg tablets, free dosing regiment with max. of 4 tablets o.d., treatment duration: up to 24 months

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Movetis
All Listed Sponsors
lead

Movetis

INDUSTRY